TY - GEN 
AU - Trompetero, Adriana
AU - Gordillo, Aldemar
AU - del Pilar, Mora Carolina
AU - Velasquillo, María Cristina
AU - Bustos Cruz, Rosa Helena
PY - 2018
UR - http://hdl.handle.net/10818/56651
AB - Neurodegenerative disorders (NDDs) are characterized by the progressive loss of structure or neuron function, often associated with neuronal death. Treatments for neurodegenerative diseases only address symptoms without having any disease-modifying...
AB - Los trastornos neurodegenerativos (NDD) se caracterizan por la perdida progresiva de la estructura o funcion neuronal, a menudo asociada con la muerte neuronal. Los tratamientos para las enfermedades neurodegenerativas solo abordan los sintomas sin...
LA - eng
PB - Current pharmaceutical design
KW - Enfermedad de Alzheimer (EA)
KW - Barrera hematoencefalica (BHE)
KW - Enfermedad de Parkinson (EP)
KW - Astrocitos
KW - Administracion de farmacos dndrimeros
KW - Celulas gliales
KW - Liposoma
KW - Nanoportador
KW - Nanoliposoma
KW - Nanomicela
KW - Nanoparticula (NP)
KW - Nanotecnologia
KW - Punto cuantico
KW - Alzheimer's disease (AD)
KW - Blood-brain barrier (BBB)
KW - Parkinson's disease (PD)
KW - Astrocyte
KW - Dndrimerrug delivery
KW - Glial cell
KW - Liposome
KW - Nanocarrier
KW - Nanoliposome
KW - Nanomicelle
KW - Nanoparticle (NP)
KW - Nanotechnology
KW - Quantum dot
TI - Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach
DO - 10.2174/1381612823666170828133059
ER -